ME/CFS in Kids: The Misunderstood Condition Doctors Are Too Quick to Dismiss

A teenager misses three months of school. Her pediatrician says she’s depressed and should exercise more. Her parents try. Every time she does, she crashes for two days — exhausted, foggy, barely able to get out of bed. This pattern repeats until a different physician recognizes post-exertional malaise, the defining feature of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, and the family finally understands why the advice to push through it made everything worse. ME/CFS is among the most controversial and least understood conditions in pediatric medicine. It is real — the CDC, NIH, and National Academy of Medicine all recognize it as a serious, multisystem illness. It is biologically grounded — research has identified immune, metabolic, and neurological abnormalities in patients. And it is chronically underfunded, underdiagnosed, and too often dismissed as psychological by providers who lack training in its presentation and management.

Key Takeaways

• ME/CFS affects an estimated 1–2.5% of adolescents, making it more common than most parents realize. It is significantly underdiagnosed.
• Post-exertional malaise (PEM) — a distinctive worsening of symptoms following physical or cognitive exertion, often with a delay of 12–48 hours — is the hallmark symptom that distinguishes ME/CFS from other fatigue conditions.
• The CDC recognizes ME/CFS as a serious, chronic illness with no established cure. Current management is symptom-based and focused on preventing exacerbations.
• “Push through it” advice and aggressive graded exercise therapy can cause significant harm in patients with true ME/CFS and PEM.
• Long COVID has substantially increased the number of children developing ME/CFS-like illness; the conditions share significant biological overlap.

What ME/CFS Is — and What Distinguishes It

ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) is a complex, multisystem illness characterized by profound fatigue, post-exertional malaise, unrefreshing sleep, cognitive difficulties, and in many patients, orthostatic intolerance (symptoms worsened by being upright).

The name is contested — “chronic fatigue syndrome” is considered misleading by patient and research communities because it implies the primary problem is being tired, which significantly understates the condition. “Myalgic Encephalomyelitis” emphasizes the neurological and inflammatory features, which are increasingly supported by research.

The four core criteria for ME/CFS diagnosis (CDC’s current framework, based on the 2015 National Academy of Medicine report):

1. A substantial reduction or impairment in ability to engage in pre-illness level of activity, lasting more than 6 months
2. Post-exertional malaise (PEM) — the hallmark symptom
3. Unrefreshing sleep
4. At least one of: cognitive impairment or orthostatic intolerance

These symptoms must cause significant functional impairment and must not be explained by another diagnosis.

The post-exertional malaise criterion is the most diagnostically distinctive. PEM is not the normal fatigue after vigorous exercise. It is a pathological worsening of all ME/CFS symptoms — fatigue, cognitive fog, pain, sleep disruption — following physical or cognitive exertion that would previously have been tolerated. The worsening is often delayed 12–48 hours after the triggering activity, making the connection less obvious. And it is not prevented by “warming up” or “building tolerance” — unlike normal exercise fatigue, which improves with conditioning, PEM in ME/CFS does not improve with graduated physical activity when the activity exceeds the patient’s threshold.

Why ME/CFS Is Dismissed

The combination of features that makes ME/CFS clinically real is the same combination that makes it easy to dismiss:

No diagnostic biomarker. Standard blood tests, imaging, and physical exams are usually normal in ME/CFS. This leads some providers to conclude that nothing is wrong, when in fact the abnormalities in ME/CFS (mitochondrial dysfunction, immune activation markers, altered gene expression) require specialized testing not performed in routine clinical care.

Symptoms overlap with psychiatric conditions. Fatigue, cognitive difficulties, and sleep problems are core depression symptoms. Many patients with ME/CFS are misdiagnosed with depression, anxiety, or psychosomatic illness — and treated accordingly, which doesn’t help and may harm if it involves pushing through fatigue.

Provider knowledge gaps. ME/CFS receives relatively little attention in medical education. Many primary care physicians and pediatricians have not received specific training in its diagnostic criteria and management. The 2015 National Academy of Medicine report estimated that 84% to 91% of people with ME/CFS in the U.S. are undiagnosed.

Patients look well. A child with ME/CFS lying on a couch, appearing physically normal, may not look sick in the way adults expect sick children to look. The illness is invisible.

ME/CFS vs. Similar Conditions: Symptom Overlap Table

Feature	ME/CFS	Major Depression	Chronic Lyme Disease	Long COVID
Profound fatigue	Yes	Yes	Yes	Yes
Post-exertional malaise (hallmark)	Yes — defining	Unusual	Sometimes	Common — shares mechanism
Unrefreshing sleep	Yes	Sometimes	Sometimes	Common
Cognitive fog	Yes — prominent	Yes	Sometimes	Common
Orthostatic intolerance	Common	Unusual	Uncommon	Common
Worsens with activity	Yes — characteristic	Typically improves with activity	Varies	Yes — overlaps significantly
Onset pattern	Often post-infectious	Gradual or life-event related	Post-tick bite	Post-COVID infection
Standard labs	Typically normal	Typically normal	Lyme serology	Typically normal
Treatment response to exercise	Can cause PEM flares	Typically improves with exercise	Varies	PEM common

The Graded Exercise Therapy Controversy

For many years, graded exercise therapy (GET) — a structured program of progressively increasing physical activity — was recommended as a primary treatment for ME/CFS, based on the theory that deconditioning and abnormal illness beliefs were maintaining the illness. Multiple clinical guidelines in the UK and elsewhere endorsed GET.

The evidence supporting GET has since been substantially challenged, and the theoretical framework underlying it (the “fear-avoidance” model) has not held up in the research.

The PACE trial — the largest randomized controlled trial of GET for ME/CFS — initially showed modest benefit. However, subsequent reanalysis of the data (after participants with PEM were separated from those without) and criticism of the trial’s methodology led to major reassessment. The UK’s NICE (National Institute for Health and Care Excellence) updated its ME/CFS guidelines in 2021 to explicitly recommend against graded exercise therapy, citing evidence that it causes harm in patients with true ME/CFS and PEM.

The current position: exercise that is carefully paced to stay below the patient’s exacerbation threshold is appropriate. Progressive exercise that pushes through PEM is not. This is a specific and important distinction. A child with ME/CFS doing gentle, paced walking within their energy envelope is different from a child being pushed to do progressively more activity under the theory that they will adapt.

School Accommodations for ME/CFS

Children with ME/CFS often cannot attend school full-time, and the pattern of attendance and cognitive capacity fluctuates unpredictably — which schools frequently interpret as avoidance behavior or lack of motivation. Parents need to understand the accommodation framework.

Section 504 is the most common mechanism for ME/CFS accommodations. Because ME/CFS substantially limits major life activities (learning, walking, breathing, concentrating), affected students qualify for 504 protections.

Common accommodations include:

• Reduced or part-time school schedule
• Rest breaks during the school day
• Extended time on all tests and assignments
• Home-to-school instruction or virtual attendance options
• Excused absences for symptom flares without academic penalty
• Reduced course load without grade penalty
• Permission for oral instead of written exams when cognitive fatigue is acute

An IEP may be appropriate if the cognitive impact of ME/CFS rises to the level of a specific learning disability, though 504 is more commonly the right vehicle.

Medical documentation from the treating physician explaining the functional limitations and their variability is important for 504 plans, particularly because ME/CFS’s fluctuating course can make it appear to skeptical school administrators that the student is selectively incapacitated.

Energy Envelope Management: The Evidence-Based Approach

The most evidence-supported management approach for ME/CFS — the one recommended by the CDC, the ME Association, and most specialists — is “energy envelope” management, also called pacing.

The core principle: every patient with ME/CFS has a ceiling of activity that, when exceeded, triggers PEM. Managing the illness means identifying and staying within that envelope — doing less than you think you could, to avoid the crash.

This is counterintuitive. It requires that a child who has some energy on a good day resists the impulse to use all of it, because doing so will cause a several-day setback. Parents find this difficult to enforce, particularly when the child wants to participate in activities they’ve missed. But consistent pacing is the most powerful tool currently available for preventing deterioration and creating the conditions for gradual recovery.

Heart rate monitoring can help — many patients use a threshold heart rate (often 60–70% of max heart rate) as an objective indicator of when to stop activity. Staying below this threshold during all physical activity reduces PEM incidence.

What to Watch For Over 3 Months

Month 1: Establish PEM tracking. For two weeks, have the child track daily activity level and symptom severity (on a simple 1–10 scale) in a diary. Look for the relationship: does Tuesday’s activity correlate with Wednesday’s or Thursday’s symptom spike? Identifying this pattern is the foundation for energy management.

Month 2: Seek appropriate specialist referral. ME/CFS should be managed by a provider familiar with the condition. Many general pediatricians lack this familiarity. Ask for referral to a pediatric specialist in ME/CFS, or to a hospital system with an established post-viral illness clinic (many have expanded these after long COVID).

Month 3: Assess the school accommodation plan. Is the current arrangement reducing the child’s PEM events? Is the child able to engage with some schoolwork consistently, or are they still crashing after any cognitive effort? Adjustments to accommodate may be needed.

Red flags: Significant deterioration rather than stability over 3 months, development of new or severe cardiac symptoms (chest pain, palpitations during minimal activity), inability to tolerate any upright position (severe orthostatic intolerance), or inability to maintain adequate nutrition and hydration all warrant urgent specialist evaluation.

Frequently Asked Questions

How is ME/CFS diagnosed in children?

Diagnosis is clinical, based on the four criteria from the 2015 National Academy of Medicine report: substantial reduction in pre-illness activity (lasting 6+ months), post-exertional malaise, unrefreshing sleep, and at least one of cognitive impairment or orthostatic intolerance. Extensive testing is typically done to exclude other causes (thyroid disease, autoimmune conditions, mood disorders, sleep apnea). There is no confirmatory biomarker. Many specialists require that symptoms persist for at least 6 months — though a working diagnosis can guide management earlier.

Is ME/CFS the same as long COVID?

They share significant overlap in symptoms, diagnostic criteria, and biological features. Many researchers believe long COVID — in cases meeting the criteria for PEM, unrefreshing sleep, and cognitive impairment — represents a form of ME/CFS triggered by SARS-CoV-2. The CDC explicitly notes the overlap. They are likely on the same biological spectrum, and management approaches for long COVID with PEM follow ME/CFS principles.

Will my child recover?

Recovery from ME/CFS, particularly when it begins in adolescence with a clear post-infectious onset, is more common than in adults. Some research suggests that approximately 50–60% of adolescent-onset ME/CFS patients achieve substantial improvement or recovery over several years. Others continue to have significant symptoms into adulthood. The factors most strongly associated with better outcomes are early diagnosis and appropriate management (avoiding PEM-triggering activity), adequate social support, and the absence of severe baseline illness.

What should I say to a provider who dismisses my child’s symptoms as psychological?

Ask the provider specifically how they are ruling out ME/CFS and whether they are using the 2015 National Academy of Medicine criteria. Request testing to exclude other causes. If the provider is not able to explain their diagnostic process and is attributing symptoms to anxiety or psychosomatic causes without that workup, request a referral to a specialist — a pediatric infectious disease specialist, rheumatologist, or physician at a post-viral illness clinic is a reasonable starting point.

---

About the author

Ricky Flores is the founder of HiWave Makers and an electrical engineer with 15+ years of experience building consumer technology at Apple, Samsung, and Texas Instruments. He writes about how kids learn to build, think, and create in a tech-saturated world. Read more at hiwavemakers.com.

---

Sources

1. National Academy of Medicine. (2015). “Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness.” Washington, D.C.: National Academies Press. https://doi.org/10.17226/19012
2. Centers for Disease Control and Prevention. (2024). “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).” https://www.cdc.gov/me-cfs/
3. NICE (National Institute for Health and Care Excellence). (2021). “Myalgic Encephalomyelitis (or Encephalopathy)/Chronic Fatigue Syndrome: Diagnosis and Management.” NICE Guideline NG206. https://www.nice.org.uk/guidance/ng206
4. Crawley, E., Sterne, J.A., et al. (2011). “Treatment Outcome in Adults with Chronic Fatigue Syndrome: A Prospective Study in England.” BMJ Open, 1(1). https://doi.org/10.1136/bmjopen-2010-000277
5. Jason, L.A., Jordan, K., Miike, T., et al. (2006). “A Pediatric Case Definition for ME/CFS.” Journal of Chronic Fatigue Syndrome, 13(2–3), pp. 1–44.
6. Rowe, K. (2019). “Long Term Follow Up of Young People with Chronic Fatigue Syndrome Attending a Pediatric Outpatient Service.” Frontiers in Pediatrics, 7, p. 21. https://doi.org/10.3389/fped.2019.00021
7. Cortes Rivera, M., Mastronardi, C., Silva-Aldana, C.T., et al. (2019). “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review.” Diagnostics, 9(3), p. 91. https://doi.org/10.3390/diagnostics9030091